GlassScriptPhysician profile
Sulayman E Jallow
NPI 1871555128
$2,090.00
in general payments reported to CMS, 2019-2025
17 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $91.75 · 2021: $292 · 2022: $369 · 2023: $393 · 2024: $381 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157 · Education: $28.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.00 |
| Education | $28.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $566.15 | 2021-2025 | Acthar |
| Abbvie INC. | $354.52 | 2022-2025 | |
| Allergan, INC. | $208.17 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $192.58 | 2024-2025 | Miebo, Xiidra, Lotemax Sm |
| Ani Pharmaceuticals, INC. | $180.48 | 2023-2024 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $141.01 | 2024-2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $63.70 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $63.22 | 2019-2021 | |
| Horizon Therapeutics Plc | $49.02 | 2022 | |
| Apellis Pharmaceuticals, INC. | $46.87 | 2023-2025 | Syfovre |
| Genentech USA, INC. | $44.50 | 2019-2025 | Vabysmo |
| Amgen INC. | $41.25 | 2025 | Tepezza |
| Alcon Vision LLC | $40.50 | 2022 | |
| Thea Pharma INC. | $32.38 | 2024 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $24.07 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.22 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sulayman Jallow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.